{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:29:08Z","timestamp":1788305348451,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,13]],"date-time":"2027-01-13T00:00:00Z","timestamp":1799798400000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD-100929"],"award-info":[{"award-number":["R01HD-100929"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI-176244"],"award-info":[{"award-number":["U01AI-176244"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011112","name":"UCB Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR-087521"],"award-info":[{"award-number":["R01AR-087521"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["N01AR-42220"],"award-info":[{"award-number":["N01AR-42220"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ard.2025.09.011","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T14:07:10Z","timestamp":1760796430000},"page":"164-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study"],"prefix":"10.1016","volume":"85","author":[{"given":"Philip M.","family":"Carlucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina F.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin S.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus B.","family":"Worthing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Izmirly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalani","family":"Sachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary T.","family":"Donofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Buyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.09.011_bib0001","series-title":"Systemic lupus erythematosus","first-page":"507","article-title":"Chapter 53 - neonatal lupus: clinical spectrum, biomarkers, pathogenesis, and approach to treatment","author":"Buyon","year":"2020"},{"issue":"5","key":"10.1016\/j.ard.2025.09.011_bib0002","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"18","key":"10.1016\/j.ard.2025.09.011_bib0003","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ard.2025.09.011_bib0004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/annrheumdis-2019-215900","article-title":"Factors associated with long-term cardiac dysfunction in neonatal lupus","volume":"79","author":"Saxena","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.09.011_bib0005","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2008.088054","article-title":"Disease progression in mothers of children enrolled in the research registry for neonatal lupus","volume":"68","author":"Rivera","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ard.2025.09.011_bib0006","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-120-7-199404010-00003","article-title":"Autoantibody-associated congenital heart block: outcome in mothers and children","volume":"120","author":"Waltuck","year":"1994","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ard.2025.09.011_bib0007","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","article-title":"Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women","volume":"44","author":"Brucato","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ard.2025.09.011_bib0008","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","article-title":"Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies","volume":"142","author":"Cimaz","year":"2003","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.ard.2025.09.011_bib0009","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/art.42733","article-title":"Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA\/Ro pregnancies","volume":"76","author":"Buyon","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2025.09.011_bib0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ard.2025.09.011_bib0011","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ard.2025.09.011_bib0012","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/1529-0131(200102)44:2<487::AID-ANR70>3.0.CO;2-D","article-title":"The rate of recurrence of isolated congenital heart block: a population-based study","volume":"44","author":"Julkunen","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ard.2025.09.011_bib0013","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ard.2025.09.011_bib0014","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2665-9913(24)00331-X","article-title":"Substantiation of trophoblast transport of maternal anti-SSA\/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade","volume":"7","author":"Buyon","year":"2025","journal-title":"Lancet Rheumatol"},{"issue":"16","key":"10.1016\/j.ard.2025.09.011_bib0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMra2312718","article-title":"Neonatal Fc receptor - biology and therapeutics","volume":"392","author":"Bussel","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ard.2025.09.011_bib0016","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa2314466","article-title":"Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn","volume":"391","author":"Jr","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ard.2025.09.011_bib0017","first-page":"1111","article-title":"Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration","volume":"10","author":"Smith","year":"2018","journal-title":"MAbs"},{"issue":"5","key":"10.1016\/j.ard.2025.09.011_bib0018","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(23)00077-7","article-title":"Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study","volume":"22","author":"Bril","year":"2023","journal-title":"Lancet Neurol"},{"issue":"24","key":"10.1016\/j.ard.2025.09.011_bib0019","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ard.2025.09.011_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ard.2025.09.011_bib0021","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2025.09.011_bib0022","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ard.2025.09.011_bib0023","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2025.09.011_bib0024","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/art.42513","article-title":"Maternal anti-Ro antibody titers obtained with commercially available immunoassays are strongly associated with immune-mediated fetal heart disease","volume":"75","author":"Jaeggi","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2025.09.011_bib0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ard.2025.09.011_bib0026","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ard.2025.09.011_bib0027","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.09.011_bib0028","first-page":"116","article-title":"Pharmacokinetic-pharmacodynamic modelling of the anti-FcRn monoclonal antibody rozanolixizumab: translation from preclinical stages to the clinic","volume":"11","author":"Lledo-Garcia","year":"2022","journal-title":"CPT: Pharmacometrics Syst Pharmacol"},{"issue":"1","key":"10.1016\/j.ard.2025.09.011_bib0029","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2461191","article-title":"Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties","volume":"17","author":"Seth","year":"2025","journal-title":"MAbs"},{"issue":"2","key":"10.1016\/j.ard.2025.09.011_bib0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/19420862.2015.1008353","article-title":"The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity","volume":"7","author":"Abdiche","year":"2015","journal-title":"MAbs"},{"issue":"4","key":"10.1016\/j.ard.2025.09.011_bib0031","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/art.27333","article-title":"Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block","volume":"62","author":"Izmirly","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ard.2025.09.011_bib0032","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1067\/mpd.2000.109108","article-title":"Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry","volume":"137","author":"Neiman","year":"2000","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.ard.2025.09.011_bib0033","article-title":"Long-term use of efgartigimod alfa in treating a young adult with childhood-onset systemic lupus erythematosus and generalized myasthenia gravis","volume":"2","author":"Nagatani","year":"2024","journal-title":"Brain Dev Case Rep"},{"key":"10.1016\/j.ard.2025.09.011_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108823","article-title":"Evaluation of the effect of rozanolixizumab on pregnancy outcomes and pre- and postnatal development in cynomolgus monkeys","volume":"132","author":"Cauvin","year":"2025","journal-title":"Reprod Toxicol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725044176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725044176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:52:28Z","timestamp":1777377148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725044176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0003496725044176"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.09.011","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking the neonatal Fc receptor as a novel approach to prevent cardiac neonatal lupus: a proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}